← Evidence map

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2015

Should adjuvant weekly paclitaxel be considered less efficacious than anthracyclines plus cyclophosphamide for lower-risk patients with early-stage breast cancer?

Vito Amoroso et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 25512451